NCT01413516 - Varenicline In-Patient Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions

Smoking Cessation

Interventions

BEHAVIORAL

Smoking cessation counseling

Counseling sessions provided by a trained smoking counselor

DRUG

Placebo

Sugar pill without any active medication

DRUG

Varenicline

Varenicline (an approved medication for smoking cessation)

Trial Locations (1)

Stanford Hospital and Clinics, Stanford